Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94

SIMPLE SUMMARY: Neuroblastoma, the most common extracranial malignancy of childhood, shows a highly variable course of disease ranging from spontaneous regression or maturation into a benign tumor to an aggressive and intractable cancer in up to 60% of patients. To adapt treatment intensity, risk st...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiedler, Stefan, Ambros, Inge M., Glogova, Evgenia, Benesch, Martin, Urban, Christian, Mayer, Marlene, Ebetsberger-Dachs, Georg, Bardi, Edit, Jones, Neil, Gamper, Agnes, Meister, Bernhard, Crazzolara, Roman, Amann, Gabriele, Dieckmann, Karin, Horcher, Ernst, Kerbl, Reinhold, Brunner-Herglotz, Bettina, Ziegler, Andrea, Ambros, Peter F., Ladenstein, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867286/
https://www.ncbi.nlm.nih.gov/pubmed/33540616
http://dx.doi.org/10.3390/cancers13030572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867286/
https://www.ncbi.nlm.nih.gov/pubmed/33540616
http://dx.doi.org/10.3390/cancers13030572

Ejemplares similares